DLL3 (Delta Like Canonical Notch Ligand 3), is also known as SCDO1. It is a member of ligand protein family, functioned as Notch ligand, and play a important role in somitogensis. Mutations in this gene cause autosomal recessive spondylocostal dysostosis 1. DLL3 is also overexpression in neuroendocrine tumors, which has been identified as a potential target for tumor therapy. Rovapituzumab tesirine, which targeted DLL3, have been used as experimental treatment of lung cancer.
Egf1 fibropellin I also known as EGF1. EGF1 peptide may be a good target head for delivering drugs to TF in anticoagulation therapy.